Haematological toxicity of clozapine and some other drugs used in psychiatry

Human Psychopharmacology

Volumn 26, Issue 2, 2011, Pages 112-119

  Nooijen, Patty M M ^a,b   Carvalho, Felix ^c   Flanagan, Robert J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

agranulocytosis; antipsychotics; clozapine; neutropenia; olanzapine

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PHENYTOIN; QUETIAPINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RISPERIDONE; VALPROIC ACID;

AGRANULOCYTOSIS; BLOOD TOXICITY; DRUG MONITORING; DRUG SAFETY; GRANULOCYTE; HUMAN; HYPONATREMIA; LEUKOCYTE COUNT; MEAN CORPUSCULAR VOLUME; NEUTROPENIA; NEUTROPHIL COUNT; PANCYTOPENIA; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGRANULOCYTOSIS; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HEMATOLOGIC DISEASES; HUMANS; MENTAL DISORDERS; NEUTROPENIA;

EID: 79956259714     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1181     Document Type: Review

References (80)

1. Andersohn F, Konzen C, Garbe E,. 2007. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146: 657-665. (Pubitemid 351650522)
2. Ahn YM, Kim K, Kim YS,. 2008. Three cases of reversible agranulocytosisafter treatment with lamotrigine. Psychiatry Investig 5: 121-123. (Pubitemid 351961758)
3. Athanasiou MC, Dettling M, Cascorbi I, et al,. 2010. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. J Clin Psychiatry. Sep 21 [epub ahead of print].
4. Bergemann N, Abu-Tair F, Aderjan R, Kopitz J,. 2007. Treatment of clozapine-induced granulocytopenia with lithium (two observations). Prog Neuropsychopharmacol Biol Psychiatry 31: 1068-1071.
5. Berk M, Fitzsimons J, Lambert T, et al,. 2007. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs 21: 117-127.
6. Blackman G,. 2008. Benign ethnic neutropenia and clozapine monitoring. J Am Acad Child Adolesc Psychiatry 47: 967-968.
7. Bogers JP,. 2007. Granulocytopenia while using clozapine: continuing or stopping treatment. Tijdschr Psychiatry 49: 575-579.
8. Bray A,. 2008. Ethnic neutropenia and clozapine. Aust N Z J Psychiatry 42: 342-345. (Pubitemid 351386495)
9. Brunoni AR, Kobuti Ferreira LR, Gallucci-Neto J, Elkis H, Velloso ED, Vinicius Zanetti M,. 2008. Lithium as a treatment of clozapine-induced neutropenia: a case report. Prog Neuropsychopharmacol Biol Psychiatry 32: 2006-2007.
10. Buchanan JA, Oyer RJ, Patel NR, et al,. 2010. A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 6: 160-164.
11. Cabral CG, de Castro M, das Neves L, Nicolato R, Lauar H, Salgado JV,. 2007. Hematological alterations associated to olanzapine use after clozapine-induced neutropenia. Rev Bras Psiquiatr 29: 93. (Pubitemid 46572479)
12. Charbonneau K, Landry P,. 2008. Leukopenia and neutropenia after intoxication with diphenhydramine (Nytol) during clozapine treatment. J Clin Psychopharmacol 28: 706-707.
13. Chaves AC, Yamauti AC, Timerman NJ,. 2008. Leucopenia and neutropenia secondary to a lymphoma in a patient exposed to several antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 32: 901-902. (Pubitemid 351313921)
14. Civalier KA, Krahn LE, Agrwal N,. 2009. Repeated episodes of neutropenia triggered by mirtazapine. Psychosomatics 50: 299-300.
15. Delieu JM, Horobin RW, Duguid JK,. 2009. Exploring the relationship of drug-induced neutrophil immaturity & haematological toxicity to drug chemistry using quantitative structure-activity models. Med Chem 5: 7-14.
16. Dietrich-Muszalska A, Olas B,. 2009. The changes of aggregability of blood platelets in schizophrenia. World J Biol Psychiatry 10: 171-176.
17. Eseonu C, Carlson J,. 2010. Clozapine rechallenge in refractory schizophrenia. Am J Psychiatr 167: 602-603.
18. Esposito D,. 2007. Comment on lithium and clozapine rechallenge: a retrospective case analysis. J Clin Psychiatry 68: 635; author reply 635. (Pubitemid 46663049)
19. Fehsel K, Loeffler S, Krieger K, et al,. 2005. Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. J Clin Psychopharmacol 25: 419-426. (Pubitemid 41368363)
20. Flanagan RJ, Dunk L,. 2008. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol 23 (Suppl 1): 27-41. (Pubitemid 351166610)
21. Focosi D, Azzarà A, Kast RE, Carulli G, Petrini M,. 2009. Lithium and hematology: established and proposed uses. J Leukoc Biol 85: 20-28.
22. Gagliano A, Masi G,. 2009. Clozapine-aripiprazole association in a 7-year-old girl with schizophrenia: clinical efficacy and successful management of neutropenia with lithium. J Child Adolesc Psychopharmacol 19: 595-598.
23. Garbe E,. 2007. Non-chemotherapy drug-induced agranulocytosis. Expert Opin Drug Saf 6: 323-335. (Pubitemid 46772850)
24. Gerbino-Rosen G, Roofeh D, Tompkins DA, et al,. 2005. Hematological adverse events in clozapine-treated children and adolescents. J Am Acad Child Adolesc Psychiatr 44: 1024-1031. (Pubitemid 41377558)
25. Gogtay N, Rapoport J,. 2008. Clozapine use in children and adolescents. Expert Opin Pharmacother 9: 459-465. (Pubitemid 351291789)
26. Grueneberger EC, Maria Rountree E, Baron Short E, Kahn DA,. 2009. Neurotoxicity with therapeutic lithium levels: a case report. J Psychiatr Pract 15: 60-63.
27. Haddy TB, Rana SR, Castro O,. 1999. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 133: 15-22. (Pubitemid 29032412)
28. Hodgson RE, Mendis S,. 2010. Lithium enabling use of clozapine in a patient with pre-existing neutropenia. Br J Hosp Med (Lond) 71: 535.
29. Hughes D, Morcos M,. 2008. Use of aripiprazole in treatment resistant schizophrenia. J Psychopharmacol 22: 927-928.
30. IgrutinoviÄ Z, ObradoviÄ S, VuletiÄ B, MarkoviÄ S,. 2008. Impact of valproates on haemostasis and blood cell count in children. Srp Arh Celok Lek 136: 267-273.
31. Iverson S, Kautiainen A, Ip J, Uetrecht JP,. 2010. Effect of clozapine on neutrophil kinetics in rabbits. Chem Res Toxicol 23: 1184-1191.
32. Jagadheesan K, Mehrtens J,. 2007. Prolongation of clozapine-induced neutropenia with olanzapine. Aust N Z J Psychiatr 41: 192 (Pubitemid 46705633)
33. Jaquenoud S, Knezevic E, Morena B, et al,. 2009. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. J Clin Psychopharmacol 29: 319-326.
34. Joffe G, Eskelinen S, Sailas E,. 2009. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis. Am J Psychiatr 166: 236.
35. Kassahun K, Mattiuz E, Franklin R, Gillespie T,. 1998. Olanzapine 10-N-glucuronide.A tertiary N-Glucuronide unique to humans. Drug Metab Dispos 26: 848-855. (Pubitemid 28452050)
36. Kassahun K, Mattiuz E, Nyhart E Jr, et al,. 1997. Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Drug Metab Dispos 25: 81-93. (Pubitemid 27045138)
37. Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM,. 2006. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Psychiatr Q 77: 81-95. (Pubitemid 43060798)
38. Kelly DL, McMahon RP, Liu F, et al,. 2010. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. J Clin Psychiatr 71: 304-311.
39. Keown P, McAllister-Williams H, Young A,. 2006. A case ofpancytopenia. J Psychopharmacol 20: 690-692.
40. Khan AY, Golewale MH, Kahn DA,. 2008. A case of chronic drug-induced neutropenia. J Psychiatr Pract 14: 246-250.
41. Kim Y, Kim BN, Cho SC, Kim JW, Shin MS,. 2008. Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents. Hum Psychopharmacol Clin Exp 23: 715-722.
42. Lahdelma L, Oja S, Korhonen M, Andersson LC, 2010. Clozapine is cytotoxic to primary cultures of human bone marrow mesenchymal stromal cells. J Clin Psychopharmacol 30: 461-463.
43. Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis EJ,. 1990. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatr 47: 945-948. (Pubitemid 20348482)
44. Lu W, Uetrecht JP,. 2008. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab Dispos 36: 1624-1636.
45. Majczenko TG, Stewart JT,. 2008. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis. South Med J 101: 639-640.
46. Mao M, Matimba A, Scordo MG, et al,. 2009. Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysis. Pharmacogenomics 10: 1447-1455.
47. Mathewson KA, Lindenmayer JP,. 2007. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia. J Clin Psychopharmacol 27: 714-715. (Pubitemid 351339465)
48. Mattai A, Fung L, Bakalar J, et al,. 2009. Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children. Hum Psychopharmacol 24: 584-589.
49. Mintzer DM, Billet SN, Chmielewski L,. 2009. Drug-induced hematologic syndromes. Adv Hematol 2009: 495863.
50. Müller-Oerlinghausen B, Lewitzka U,. 2010. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology 62: 43-49.
51. Nykiel S, Henderson D, Bhide G, Freudenreich O,. 2010. Lithium to allow clozapine prescribing in benign ethnic neutropenia. Clin Schizophr Relat Psychoses 4: 138-140.
52. Opgen-Rhein C, Dettling M,. 2008. Clozapine-induced agranulocytosis and its genetic determinants. Pharmacogenomics 9: 1101-1111.
53. Palominao A, Kukoyi O, Xiong GL,. 2010. Leukocytosis after lithium and clozapine combination therapy. Ann Clin Psychiatry 22: 205-206.
54. Papetti F, Darcourt G, Giordana JY, et al,. 2004. Treatment of clozapine-induced granulocytopenia with lithium (two observations). Encephale 30: 578-582.
55. Paton C, Esop R,. 2005. Managing clozapine-induced neutropenia with lithium. Psychiatr Bull 29: 186-188. (Pubitemid 40667573)
56. Phillips D, Rezvani K, Bain BJ,. 2000. Exercise induced mobilisation of the marginated granulocyte pool in the investigation of ethnic neutropenia. J Clin Pathol 53: 481-483.
57. Pinninti NR, Houdart MP, Strouse EM,. 2010. Case report of long-term lithium for treatment and prevention of clozapine-induced neutropenia in an African American male. J Clin Psychopharmacol 30: 219-221.
58. Pontikoglou C, Papadaki HA,. 2010. Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone. Hemoglobin 34: 291-304.
59. Porter R, Mohamed A,. 2006. Diurnal variation of neutropenia during clozapine treatment. Int J Neuropsychopharmacol 9: 373-374. (Pubitemid 43780506)
60. Ragonnet L, Abadie P, Dollfus S,. 2010. Use of clozapine in an adolescent with refractory first-episode psychosis and neutropenia. J Clin Psychopharmacol 30: 336-338.
61. Rahman A, Mican LM, Fischer C, Campbell AH,. 2009. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Ann Pharmacother 43: 822-830.
62. Rajagopal G, Graham JG, Haut FF,. 2007. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor(G-CSF) in an intellectually disabled patient with schizophrenia. J Intellect Disabil Res 51: 82-85. (Pubitemid 44869821)
63. Schulte PF,. 2006. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Ann Pharmacother 40: 683-688.
64. Shankar BR,. 2007. Quetiapine-induced leucopenia and thrombocytopenia. Psychosomatics 48: 530-531. (Pubitemid 350074407)
65. Sikora A, Adamus J, Marcinek A,. 2007. Disproportionation of clozapine radical: a link between one-electron oxidation of clozapine and formation of its nitrenium cation. Chem Res Toxicol 20: 1093-1098. (Pubitemid 47372987)
66. Sissung TM, Mross K, Steinberg SM, et al,. 2006. Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia. Eur J Canc 42: 2893-2896. (Pubitemid 44755257)
67. Sopko MA, Caley CF,. 2010. Chronic leukocytosis associated with clozapine treatment. Clin Schizophr Relat Psychoses 4: 141-144.
68. Sporn A, Gogtay N, Ortiz-Aguayo R, et al,. 2003. Clozapine-induced neutropenia in children: management with lithium carbonate. J Child Adolesc Psychopharmacol 13: 401-404. (Pubitemid 37288536)
69. Srinivasaraju R, Reddy YC, Pal PK, Math SB,. 2010. Clozapine-associated cerebral venous thrombosis. J Clin Psychopharmacol 30: 335-336.
70. Stephan F, Podlipski MA, Kerleau JM, Petit M, Guillin O,. 2009. Toxicité médullaire des phénothiazines: Ã propos d'un cas d'agranulocytose sous chlorpromazine. L'Encéphale 35: 173-175.
71. Stoner SC, Deal E, Lurk JT,. 2008. Delayed-onset neutropenia with divalproex sodium. Ann Pharmacother 42: 1507-1510.
72. Taylor D, Paton C, Kerwin R,. 2007. The Maudsley Prescribing Guidelines, 9th edn. Informa Healthcare: London.
73. Thinn SS, Liew E, May AL, Chua HC, Sim K,. 2007. Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic. J Clin Psychopharmacol 27: 394-395. (Pubitemid 47075512)
74. Tiihonen J, Lönnqvist J, Wahlbeck K,. et al. 2009. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374: 620-627.
75. Tseng KC, Hwang TJ,. 2009. Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium. J Clin Psychopharmacol 29: 398-399.
76. Vasudev K, Keown P, Gibb I, McAllister-Williams RH,. 2010. Hematological effects of valproate in psychiatric patients: what are the risk factors? J Clin Psychopharmacol 30: 282-285.
77. Whiskey E, Olofinjana O, Taylor D,. 2010. The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study. J Psychopharmacol. Mar 19. [Epub ahead of print].
78. Wu SY, Liu CC, Hsieh MH,. 2008. Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents. Prog Neuropsychopharmacol Biol Psychiatry 32: 1089-1090. (Pubitemid 351609249)
79. Yalcin DO, Goka E, Aydemir MC, Kisa C,. 2008. Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report. J Psychopharmacol 22: 333-335. (Pubitemid 351847443)
80. Zhou SF, Wang B, Yang LP, Liu JP,. 2010. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 42: 268-354.